CPT 80230 — Drug assay infliximab (2026 RVU Values)
CPT code 80230 (Drug assay infliximab) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.
How Medicare handles CPT 80230
Medicare status: Not paid under the physician fee schedule. Medicare does not pay this code through the Physician Fee Schedule, so it has no work RVU value and does not count toward wRVU productivity. Payment, if any, comes through another Medicare payment system.